Cancer diagnosis may be linked with improved smoking cessation
the ONA take:
Research evidence indicates that a cancer diagnosis can stimulate smoking cessation. Little previous study research exists correlating smoking cessation with a diagnosis of cancer, though the event certainly provides the opportunity for a teachable moments in which an oncology may attempt to motivate a smoker to quit the habit.
Study author J. Lee Westmaas, PhD, and associates, based at the Behavioral Research Center, American Cancer Society, sought to determine if a link exists.
Participant data from the Cancer Prevention Study-II Nutrition Cohort was reviewed and a comparison made between the quit rates of smokers diagnosed with cancer at 2- and 4-year intervals and smokers not diagnosed with cancer. Individuals with cancers that could influence smoking (saucy as cancer of the lung or esophagus) were excluded from the review.
Both the 2-year and 4-year quit rate was found to be higher for smokers diagnosed with cancer. Even when the cancer diagnosis had a good prognosis or could not be directly linked to the smoking habit, the quit rate was found to be higher.
The investigation results suggest that a cancer diagnosis may indeed provide a teachable moment opportunity for oncology professionals.
Research evidence indicates that a cancer diagnosis can stimulate smoking cessation.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|